Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF

Getty ImagesDomestic mutual funds acquired a large Ajanta Pharma stake from a promoter entity through a…

Market correction nearing its end; bet on banking, pharma: Rohit Srivastava

ETMarkets.comOne of the most constructive sectoral outlooks offered by Srivastava was for pharmaceuticals. After a sharp…

India EU trade deal closer than ever: Jefferies lists 4 sectoral winners for stock market investors

India-EU Trade Deal Closer Than Ever: Jefferies Highlights Four Sectoral Winners for Investors India’s long-awaited free…

Can domestic formulations shield Indian pharma from US pricing pressure in Q3?

Can Domestic Formulations Shield Indian Pharma from US Pricing Pressure in Q3? iStock Lupin is anticipated…